Immune response study in primary and metastatic colon cancer
Part of Cancer, Digestive system clinical trials.
This trial studies how the immune system responds to colon cancer, especially when it has spread. Researchers want to understand and possibly boost immune reactions during surgery. It may help find better ways to treat colorectal cancer in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with colorectal cancer (cancer of the colon or rectum).
- You are scheduled for surgery to remove the tumor or any cancer that has spread (metastases).
- You do not have HIV.
- You are not pregnant or breastfeeding.
- You can understand and read study information, and are willing to follow trial procedures for 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at ways to better predict how early-stage colon cancer will respond to standard treatment. It is focused on patients who will have surgery to remove the tumor and have not yet had any other cancer treatment.
This study looks at how bacteria in your gut, your immune system, and colon cancer interact. It aims to understand these connections to improve future treatments.
This study looks for blood/tumor signals (“biomarkers”) that may help predict outcomes in people whose colorectal cancer returns and spreads after surgery. It mainly helps researchers understand who may do better or worse, which can guide future care.
This study looks at how gut bacteria and immune activity differ in normal, pre-cancer, and cancer colon tissue. It may help researchers understand what changes in the body are linked to colon growth and how they could be targeted in the future.
This Phase 2 study tests the best way to choose and then follow treatment when colorectal cancer has spread only to a small number of spots. You may be eligible if your doctors can remove or precisely treat the spots and there’s no sign of additional spread on scans.
This study follows people with colorectal, pancreatic, or bile duct cancer to learn how the body’s immune system and cancer surroundings affect disease. The results may help guide better future treatments, even though this is more of an observational cohort study.
Hear when a new Colon Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.